Bruker - About the company
Bruker is a public company based in United States, founded in 1960. It operates as a Manufacturer of high-performance scientific instruments for life sciences. Bruker has raised an undisclosed amount in funding. The company has 967 active competitors, including 65 funded and 134 that have exited. Its top competitors include companies like Illumina, Siemens Healthineers and Agilent.
Company Details
Manufacturer of high-performance scientific instruments for life sciences. The company focuses on technologies like mass spectrometry, NMR, X-ray diffraction, and microscopy to support applications in biopharma, academia, and industry.
- Website
- www.bruker.com/en.html
- Registered Address
- Billerica, Massachusetts
Key Metrics
Founded Year
1960
Location
Stage
Public
Latest Funding Round
Investors
Ranked
9th among 967 active competitors
Annual Revenue
$1B+ as on Dec 31, 2025
Employee Count
4,813 as on Apr 30, 2026
Exit Details
Public
Legal entities associated with Bruker
Bruker is associated with 5 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
REAL MSB s.r.o. CIN: 25758225 , Czech Republic, Active | Apr 27, 1999 | - | - | |
BRUKER CORP CIN: 1109354 , United States, Active | Feb 03, 2000 | $1B+ (As on Dec 31, 2025) | 9707 (As on Dec 31, 2023) | - |
BRUKER AXS ANALYTICAL INSTRUMENTS PRIVATE LIMITED CIN: U33125MH2006FTC165541 , India, Amalgamated | Nov 14, 2006 | ₹10 - ₹50 Cr (As on Mar 31, 2016) | - | |
BRUKER INDIA SCIENTIFIC PRIVATE LIMITED CIN: U33100MH1985PTC035138 , India, Active | Jan 23, 1985 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 143 (As on Feb 29, 2024) | |
BRUKER CORPORATION CIN: 331064878 , United States, Active | Dec 26, 999 | - | 2160 (As on Dec 31, 2024) | - |
Bruker's IPO details
Bruker got listed on Aug 04, 2000.
Click here to take a look at Bruker's IPO in detail
Sign up to download Bruker's company profile
Bruker's funding and investors
Bruker has raised funding over 40 rounds. Its first funding round was on Jan 2001. Its latest funding round was a Grant (prize money) round on Nov 17, 2022 for $*****. 1 investor participated in its latest round. Bruker has 7 institutional investors.
Here is the list of recent funding rounds of Bruker:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 17, 2022 | 5993868 | Grant (prize money) | 6728149 | 6163272 | 8919432 | 5656690 |
Sep 13, 2022 | 2980716 | Grant (prize money) | 2663030 | 3773801 | 6037177 | |
Nov 18, 2021 | 1136278 | Grant (prize money) | 1789687 | 2054217 | 5363346 |
View details of Bruker's funding rounds and investors
Bruker's founders and board of directors
Founder? Claim ProfileBruker's employee count trend
Bruker has 4,813 employees as of Apr 26. Here is Bruker's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bruker's Competitors and alternates
Top competitors of Bruker include Illumina, Siemens Healthineers and Agilent. Here is the list of Top 10 competitors of Bruker, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Illumina 1993, San Diego (United States), Public | Developer of technologies for analysis of genetic variation and function | $28M | 78/100 | |
2nd | Siemens Healthineers 2017, Forchheim (Germany), Public | Provider of medical imaging laboratory diagnostics and clinical digital solutions | - | 75/100 | |
3rd | Agilent 1995, Santa Clara (United States), Public | Developer of diversified instruments for scientific and laboratory management | - | 73/100 | |
4th | Quanterix 2007, Cambridge (United States), Public | Developer of assay kits for ultra-sensitive biomarker detection | $99.5M | 72/100 | |
5th | Developer of laboratory and biopharmaceutical equipment | - | 72/100 | ||
6th | Cepheid 1996, Sunnyvale (United States), Acquired | Developer of molecular diagnostic testing solutions | $19.1M | 70/100 | |
7th | Esco Lifesciences 1978, Singapore (Singapore), Late Stage | Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools | $200M | 69/100 | |
8th | Biocare Medical 1997, Concord (United States), Acquired | Manufacturer of primary antibodies and instruments for immunohistochemistry applications | $85M | 67/100 | |
9th | Bruker 1960, United States, Public | Manufacturer of high-performance scientific instruments for life sciences | - | 67/100 | |
10th | Provider of gene sequencing instruments, reagents, equipment, and related products | $1B | 66/100 |
Looking for more details on Bruker's competitors? Click here to see the top ones
Bruker's Investments and acquisitions
Bruker has made 24 investments in companies including Atinary and Mercy BioAnalytics. Bruker has also acquired 45 companies including Mimetas and Biocrates.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Aug 14, 2026 | Investments | 2020 | Lausanne (Switzerland) | |
Aug 10, 2026 | Acquisition | 2013 | Leiden (Netherlands) | |
Sep 03, 2025 | Investments | 2018 | Boston (United States) |
See all investments and acquisitions by Bruker
Reports related to Bruker
Here is the latest report on Bruker's sector:
News related to Bruker
Media has covered Bruker for a total of 53 events in the last 1 year, 36 of them have been about company updates and 4 about partnerships.
•
Bruker expects FY 2026 non-GAAP EPS of $2.10-$2.15 while targeting 250-300 bps operating margin expansion (NASDAQ:BRKR)Seeking Alpha•Nov 04, 2026•Bruker
•
Bruker Reports 2 Percent Q3 Revenue Rise, Lowers 2026 Revenue GuidancePrecision Oncology News•Nov 04, 2026•Bruker
•
•
•
•
•
•
Bruker Acquires DISQVER Clinical Metagenomics Platform to Enhance Infection Detection CapabilitiesContract Pharma•Jul 15, 2026•Noscendo, Bruker
•
Bruker Corp (BRKR) executive Wolfgang Pusch discloses 10,154 Common Stock sharesStocktitan•Jul 10, 2026•Bruker
•
Bruker Corp strengthens its position in advanced scientific instruments as investors watch long-termAd Hoc News•Jul 07, 2026•Bruker
Are you a Founder ?
FAQs about Bruker
Explore our recently published companies
- DIV Protocol - Paris based, 2025 founded, Unfunded company
- D and H Fire - San Dimas based, 2016 founded, Funding Raised company
- Eye7 Eye Hospitals - Delhi based, 1987 founded, Unfunded company
- AiLuvio - Praha based, 2023 founded, Unfunded company
- Receptive Sports Technologies - Ludhiana based, 2022 founded, Unfunded company
- Goods For Health - Delhi based, 2025 founded, Unfunded company